NIKKEI 225
38,087.80 -141.31 (-0.37%) HANG SENG
18,963.68 0.00 (0.00%) CRUDE OIL
77.92 -0.34 (-0.43%) GOLD FUTURES
2,365.80 -9.20 (-0.39%) DOW
39,512.84 +125.04 (+0.32%) Bitcoin GBP
49,049.88 +416.09 (+0.86%)
Healthwell Acquisition Corp. I (HWELW)
- Business Wire
Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate
WINNETKA, Ill., November 18, 2023--Healthwell Acquisition Corp. I ("Healthwell") (Nasdaq: HWEL) announced today that (i) its previously announced special meeting of stockholders that was scheduled for December 4, 2023 has been cancelled, and that it has withdrawn from consideration by Healthwell’s stockholders the proposals set forth in Heatlhwell’s Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on November 13, 2023 and (ii) it inten
- Business Wire
Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.
WINNETKA, Ill., November 03, 2023--Healthwell Acquisition Corp. I ("Healthwell") (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. ("Starton") was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November 3, 2023. As a result, Healthwell will seek an alternative business combinatio
- Business Wire
Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions
PARAMUS, N.J. & WINNETKA, Ill., October 24, 2023--Healthwell Acquisition Corp. I ("Healthwell," "HWEL" or the "Company") (NASDAQ: HWEL) announced today that it has postponed until further announcement the date of the special meeting of the Company’s stockholders (the "Meeting") to approve its proposed business combination with Starton Therapeutics, Inc. ("Starton") and related transactions that had been scheduled for 10:00 a.m. Eastern Time on October 25, 2023. At the Meeting, the stockholders w
